CSS
LAB icon

Cubist Systematic Strategies’s Standard BioTools LAB Stock Holding History

Cubist Systematic Strategies’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,551
Closed -$7.86K – 3288
2025
Q2 		$7.86K Buy
+6,551
New +$7.26K ﹤0.01% 2845
2024
Q2 		– Sell
-441,232
Closed -$1.2M – 3528
2024
Q1 		$1.2M Buy
441,232
+413,922
+1,516% +$999K 0.01% 2021
2023
Q4 		$60.4K Buy
27,310
+21,137
+342% +$45.1K ﹤0.01% 3250
2023
Q3 		$17.9K Sell
6,173
-9,600
-61% -$25.1K ﹤0.01% 3105
2023
Q2 		$30.4K Buy
15,773
+5,786
+58% +$11.4K ﹤0.01% 3152
2023
Q1 		$19.5K Sell
9,987
-144,990
-94% -$286K ﹤0.01% 3672
2022
Q4 		$181K Buy
154,977
+40,213
+35% +$49.5K ﹤0.01% 3625
2022
Q3 		$126K Sell
114,764
-11,038
-9% -$16.7K ﹤0.01% 3941
2022
Q2 		$201K Buy
+125,802
New +$311K ﹤0.01% 3697
2022
Q1 		– Sell
-17,760
Closed -$70K – 3673
2021
Q4 		$70K Buy
+17,760
New +$83.1K ﹤0.01% 3264
2021
Q3 		– Sell
-65,491
Closed -$403K – 3066
2021
Q2 		$403K Sell
65,491
-18,468
-22% -$98.7K ﹤0.01% 2142
2021
Q1 		$379K Buy
83,959
+54,590
+186% +$300K ﹤0.01% 2113
2020
Q4 		$176K Buy
+29,369
New +$193K ﹤0.01% 2285
2020
Q1 		– Sell
-17,187
Closed -$60K – 2305
2019
Q4 		$60K Sell
17,187
-76,296
-82% -$268K ﹤0.01% 2264
2019
Q3 		$433K Buy
93,483
+53,274
+132% +$420K 0.01% 1366
2019
Q2 		$495K Sell
40,209
-100,828
-71% -$1.28M 0.01% 1477
2019
Q1 		$1.87M Buy
141,037
+115,074
+443% +$1.21M 0.06% 470
2018
Q4 		$224K Buy
+25,963
New +$202K 0.01% 1463
2016
Q4 		– Sell
-123
Closed -$1K – 1807
2016
Q3 		$1K Buy
+123
New +$1.13K ﹤0.01% 1669
2016
Q1 		– Sell
-33,636
Closed -$364K – 1731
2015
Q4 		$364K Buy
33,636
+32,019
+1,980% +$314K 0.02% 999
2015
Q3 		$13K Sell
1,617
-5,197
-76% -$81.8K ﹤0.01% 1802
2015
Q2 		$165K Buy
+6,814
New +$215K 0.01% 1508

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Cubist Systematic Strategies's LAB Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Standard BioTools (LAB) in Q3 2025, closing a stake of 6,551 shares — an estimated $7.86K sold.

Cubist Systematic Strategies first reported a position in LAB in Q2 2015 and held it in 22 quarters. The position peaked at $1.87M in Q1 2019. 155 funds tracked by Wall St. Rank hold LAB as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Standard BioTools position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 6,551 Standard BioTools shares in Q3 2025, an estimated $7.86K.
  • Cubist Systematic Strategies first reported a position in Standard BioTools in Q2 2015 and held it in 22 quarters.
  • Cubist Systematic Strategies's Standard BioTools position peaked at $1.87M in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.